Full Text View
Tabular View
No Study Results Posted
Related Studies
The LANCET Trial: A Trial of Long-Acting Insulin Injection to Reduce C-Reactive Protein in Patients With Type 2 Diabetes
This study is ongoing, but not recruiting participants.
Study NCT00366301   Information provided by Brigham and Women's Hospital
First Received: August 17, 2006   Last Updated: February 2, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Type 2 Diabetes
Additional conditions recognized in this trial
Diabetes Mellitus
Diabetes Mellitus, Type 2
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
Insulin glargine injection
metformin
Placebo pill
Additional drug interventions recognized in this trial
Glargine
Insulin
More general drug interventions related to this trial
Hypoglycemic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Brigham and Women's Hospital
Sanofi-Aventis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services